|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development expenses, net | |||||
| Marketing and business development expenses | |||||
| General and administrative expenses | |||||
| Total operating expenses | |||||
| Operating profit (loss) | |||||
| Financial and other income, net | |||||
| Profit (loss) before taxes on income | |||||
| Taxes on income, net | |||||
| Net profit (loss) | |||||
| Basic net profit (loss) per share | |||||
| Diluted profit (loss) per ordinary share | |||||
| Other comprehensive profit (loss): | |||||
| Unrealized gain (loss) arising during the period from marketable securities | |||||
| Total comprehensive profit (loss) | |||||
| Weighted average number of ordinary shares used in computing basic net profit (loss) per share | |||||
| Weighted average number of ordinary shares used in computing diluted net profit (loss) per share |
Loading...
